Medpace Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Others were interested in
See all stocksFrequently asked questions
To buy Medpace Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Medpace Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Medpace Holdings Inc. is MEDP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Medpace Holdings Inc. has its primary listing on NASDAQ. You can trade Medpace Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Medpace Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Medpace Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Medpace Holdings Inc..